US Capitol Capsule: Group proposes efforts to ensure US innovation competitiveness
This article was originally published in Scrip
An out-of-date US federal structure unable to strategically respond to the innovation challenges of the global economy and a lack of government R&D efforts to make the most of basic and applied research generated at US universities are just some of the barriers that are inhibiting the nation's ability to compete in the 21st century, the Washington think tank Center for American Progress (CAP) insisted last week.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.